Since genetic ablation of Drosophila homolog of SRPK1 altered RAN protein (FMRpolyG‐EGFP) levels in a fly model of FXTAS, we next asked if inhibition of SRPK1 can modulate RAN translation in mammalian cells. The gene discussed is RAN; the disease is fragile X-associated tremor/ataxia syndrome.